Hideshi Ishii Selected Research

Hideshi Ishii Research Topics

Disease

124	Neoplasms (Cancer) 10/2022 - 03/2002
35	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2004
24	Neoplasm Metastasis (Metastasis) 10/2022 - 12/2004
13	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 11/2004
11	Stomach Neoplasms (Stomach Cancer) 05/2015 - 01/2006
9	Carcinogenesis 08/2018 - 01/2003
8	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2003
6	Adenocarcinoma 10/2022 - 01/2013
6	Colonic Neoplasms (Colon Cancer) 01/2019 - 12/2008
6	Leukemia 02/2015 - 05/2003
6	Esophageal Neoplasms (Esophageal Cancer) 07/2013 - 10/2004
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 07/2021 - 08/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 11/2012
4	Liver Neoplasms (Liver Cancer) 11/2012 - 09/2010
4	Lymphatic Metastasis 11/2010 - 09/2010
4	Carcinoma (Carcinomatosis) 05/2007 - 03/2002
3	Cholangiocarcinoma 03/2018 - 04/2010
3	Hypoxia (Hypoxemia) 02/2018 - 09/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2016 - 10/2004
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 03/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 06/2005
2	Hematologic Neoplasms (Hematological Malignancy) 03/2015 - 10/2008
2	Inflammation (Inflammations) 05/2013 - 03/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2008 - 11/2004

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2003
20	MicroRNAs (MicroRNA)IBA 05/2022 - 04/2011
16	Messenger RNA (mRNA)IBA 01/2022 - 11/2003
16	EnzymesIBA 10/2018 - 07/2004
11	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2004
10	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2003
10	CarbonIBA 10/2021 - 11/2015
10	Biological ProductsIBA 06/2021 - 03/2003
10	Indicators and Reagents (Reagents)IBA 11/2015 - 01/2006
10	Histidine (L-Histidine)FDA Link 07/2009 - 03/2002
9	Pharmaceutical PreparationsIBA 02/2022 - 03/2014
7	CarcinogensIBA 06/2012 - 09/2003
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2011
6	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 09/2010
5	Folic Acid (Vitamin M)FDA LinkGeneric 07/2021 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2007
4	Trifluridine (Viroptic)FDA LinkGeneric 01/2022 - 04/2017
4	6-methyladenineIBA 01/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 07/2012
4	Small Interfering RNA (siRNA)IBA 02/2018 - 03/2006
4	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2018 - 03/2014
4	Pyruvate KinaseIBA 08/2015 - 10/2014
4	Complementary DNA (cDNA)IBA 06/2012 - 11/2004
4	fragile histidine triad proteinIBA 05/2007 - 03/2002
4	nitrosobenzylmethylamineIBA 03/2005 - 01/2003
3	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 12/2004
3	Gemcitabine FDA Link 01/2019 - 09/2015
3	Epidermal Growth Factor (EGF)IBA 08/2015 - 12/2004
3	A-Form DNA (A-DNA)IBA 08/2013 - 11/2003
2	N-methyladenosineIBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2020 - 11/2003
2	LigandsIBA 01/2020 - 12/2004
2	Monocarboxylic Acid TransportersIBA 04/2019 - 03/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 08/2017
2	PolyaminesIBA 01/2019 - 01/2018
2	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 12/2018 - 01/2017
2	Serine (L-Serine)FDA Link 04/2017 - 01/2017
2	HydrolasesIBA 04/2017 - 02/2003
2	Histones (Histone)IBA 11/2016 - 11/2003
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2016 - 03/2015
2	CytokinesIBA 12/2015 - 05/2013
2	RibonucleotidesIBA 11/2015 - 01/2015
2	HexokinaseIBA 05/2015 - 09/2014
2	Green Fluorescent ProteinsIBA 12/2014 - 12/2014
2	AntibodiesIBA 09/2014 - 04/2014
2	Epithelial Cell Adhesion MoleculeIBA 04/2014 - 04/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 05/2013 - 12/2004
2	Aldehyde DehydrogenaseIBA 04/2013 - 04/2013
2	Cadherins (E-Cadherin)IBA 07/2012 - 09/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2011 - 10/2008
2	teleocalcinIBA 01/2011 - 10/2010
2	Tumor Biomarkers (Tumor Markers)IBA 12/2010 - 07/2009
2	Matrix Metalloproteinases (MMPs)IBA 12/2010 - 12/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2010 - 12/2004
2	AntigensIBA 02/2010 - 07/2009
2	Caspase 3 (Caspase-3)IBA 07/2009 - 10/2004
2	CamptothecinIBA 12/2008 - 05/2007
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2008 - 05/2007
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 12/2008 - 10/2008
2	NitrosaminesIBA 04/2008 - 11/2004
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2006 - 05/2005
2	ErbB Receptors (EGF Receptor)IBA 01/2006 - 12/2004
2	Histone Deacetylase InhibitorsIBA 01/2006 - 05/2005
2	Phosphotransferases (Kinase)IBA 01/2006 - 03/2005
2	romidepsin (FK228)FDA Link 01/2006 - 05/2005
2	DepsipeptidesIBA 01/2006 - 05/2005
2	Tyrosine Kinase InhibitorsIBA 01/2006 - 12/2004
2	ZincIBA 10/2004 - 01/2003
1	Peptides (Polypeptides)IBA 10/2022
1	Myosins (Myosin)IBA 10/2022
1	Myosin Type IIIBA 10/2022

Therapy/Procedure

33	Therapeutics 04/2022 - 03/2004
17	Drug Therapy (Chemotherapy) 06/2021 - 07/2010
8	Radiotherapy 01/2022 - 09/2010
5	Precision Medicine 04/2022 - 04/2017
4	Lasers (Laser) 06/2012 - 05/2007